Mammographic screening
Intervention1 paper2 findings
- In silico1
Outcomes
2Disease-management costs
downin silico1
1 study
Disease-management costs
downin silico1
Mammographic screening decreases disease-management costs in silico (€126.05 vs €135.84 per patient).
In silicodecision-tree modelfemales
Extension of the mammographic screening programme in Italy: cost-benefit analysis of early diagnosis in the 45-49 and 70-74 age groups · Frontiers in medicine · 10 Aug 2026
Early-stage breast cancer diagnosis
upin silico1
1 study
Early-stage breast cancer diagnosis
upin silico1
Mammographic screening increases early-stage breast cancer diagnosis in silico (approximately 19,430 vs 13,975 early-stage cases).
In silicodecision-tree modelfemales
Extension of the mammographic screening programme in Italy: cost-benefit analysis of early diagnosis in the 45-49 and 70-74 age groups · Frontiers in medicine · 10 Aug 2026